Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forma Medical has received FDA 510(k) clearance for its flagship device, the OptimalMTP® Plating System, which is dedicated to minimally invasive first ray MTP fusion. The company’s portfolio includes other commercialized implants such as OptimalHT® and OptimalAkin®. These devices are designed to improve reproducibility, efficiency, and outcomes in foot and ankle orthopedic surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forma Medical.